RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Genor Biopharma Holdings Stock

Genor Biopharma Holdings Liabilities 2024

Genor Biopharma Holdings Liabilities

258.06 M CNY

Ticker

6998.HK

ISIN

KYG3871A1004

WKN

A3C3E0

In 2024, Genor Biopharma Holdings's total liabilities amounted to 258.06 M CNY, a -17.45% difference from the 312.61 M CNY total liabilities in the previous year.

Genor Biopharma Holdings Aktienanalyse

What does Genor Biopharma Holdings do?

Genor Biopharma Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Genor Biopharma Holdings's Liabilities

Genor Biopharma Holdings's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Genor Biopharma Holdings's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Genor Biopharma Holdings's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Genor Biopharma Holdings's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Genor Biopharma Holdings’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Genor Biopharma Holdings stock

What is the level of liabilities of Genor Biopharma Holdings this year?

Genor Biopharma Holdings has a debt balance of 258.06 M CNY this year.

What were the liabilities of Genor Biopharma Holdings compared to the previous year?

The liabilities of Genor Biopharma Holdings have increased by -17.45% dropped compared to the previous year.

What are the consequences of high debt for investors of Genor Biopharma Holdings?

High liabilities can pose a risk for investors of Genor Biopharma Holdings, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Genor Biopharma Holdings?

Low liabilities mean that Genor Biopharma Holdings has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Genor Biopharma Holdings affect the company?

An increase in liabilities of Genor Biopharma Holdings can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Genor Biopharma Holdings affect the company?

A decrease in the liabilities of Genor Biopharma Holdings can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Genor Biopharma Holdings?

Some factors that can influence the liabilities of Genor Biopharma Holdings include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Genor Biopharma Holdings so important for investors?

The liabilities of Genor Biopharma Holdings are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Genor Biopharma Holdings take to modify the liabilities?

To change its liabilities, Genor Biopharma Holdings can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Genor Biopharma Holdings pay?

Over the past 12 months, Genor Biopharma Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genor Biopharma Holdings is expected to pay a dividend of 0 CNY.

What is the dividend yield of Genor Biopharma Holdings?

The current dividend yield of Genor Biopharma Holdings is .

When does Genor Biopharma Holdings pay dividends?

Genor Biopharma Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Genor Biopharma Holdings?

Genor Biopharma Holdings paid dividends every year for the past 0 years.

What is the dividend of Genor Biopharma Holdings?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Genor Biopharma Holdings located?

Genor Biopharma Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genor Biopharma Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genor Biopharma Holdings from 12/18/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.

When did Genor Biopharma Holdings pay the last dividend?

The last dividend was paid out on 12/18/2024.

What was the dividend of Genor Biopharma Holdings in the year 2023?

In the year 2023, Genor Biopharma Holdings distributed 0 CNY as dividends.

In which currency does Genor Biopharma Holdings pay out the dividend?

The dividends of Genor Biopharma Holdings are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Genor Biopharma Holdings

Our stock analysis for Genor Biopharma Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genor Biopharma Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.